The results of immunohistochemistry experiments demonstrated that the proportion of GSDME staining increased and Ki67 staining decreased in xenograft tumors following ALKBH4 knockdown (Fig. 7E), thereby providing further evidence that ALKBH4 knockdown inhibits gastric cancer proliferation. Here, ALKBH4 is linked to gastric cancer.